Context Therapeutics Inc
F:6K9
Context Therapeutics Inc
F:6K9
Price:
0.446
EUR
-3.04%
Market Cap:
€33.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Context Therapeutics Inc
F:6K9
|
US |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
First Majestic Silver Corp
TSX:FR
|
CA |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
Grab Holdings Ltd
F:A6I
|
SG |
|
P
|
Promotora y Operadora de Infraestructura SAB de CV
SWB:AKY
|
MX |
|
Maxell Ltd
OTC:MXLLF
|
JP |
|
Absa Group Ltd
F:AU61
|
ZA |
|
Sinopec Oilfield Service Corp
SSE:600871
|
CN |
|
G
|
General Dynamics Corp
DUS:GDX
|
US |
|
Southstone Minerals Ltd
XTSX:SML
|
CA |
|
N
|
Nordstrom Inc
DUS:NRD
|
US |
|
N
|
Netflix Inc
F:NFC
|
US |
Wall St Price Targets
6K9 Price Targets Summary
Context Therapeutics Inc
Context Therapeutics Inc
Wall Street analysts forecast 6K9 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 6K9 is 3.707 EUR with a low forecast of 2.447 EUR and a high forecast of 5.088 EUR.
Lowest Forecast
Price Target
2.447
EUR
449% Upside
Average Forecast
Price Target
3.707
EUR
731% Upside
Highest Forecast
Price Target
5.088
EUR
1 041% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6K9's stock price target?
Price Target
3.707
EUR
3.707
EUR
According to Wall Street analysts, the average 1-year price target for 6K9 is 3.707 EUR with a low forecast of 2.447 EUR and a high forecast of 5.088 EUR.
